GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,118,321 | +14.4% | 163,511 | +37.2% | 0.00% | 0.0% |
| Q2 2023 | $7,093,834 | +9.1% | 119,144 | +3.8% | 0.00% | 0.0% |
| Q1 2023 | $6,500,799 | -24.9% | 114,774 | -1.5% | 0.00% | -25.0% |
| Q4 2022 | $8,656,020 | +22.7% | 116,548 | -1.6% | 0.00% | +33.3% |
| Q3 2022 | $7,053,000 | +1.9% | 118,395 | -4.0% | 0.00% | 0.0% |
| Q2 2022 | $6,921,000 | -40.3% | 123,282 | -21.5% | 0.00% | -25.0% |
| Q1 2022 | $11,586,000 | +1.5% | 157,036 | -0.7% | 0.00% | 0.0% |
| Q4 2021 | $11,420,000 | -5.2% | 158,175 | +0.6% | 0.00% | -20.0% |
| Q3 2021 | $12,044,000 | -1.7% | 157,192 | -0.5% | 0.01% | 0.0% |
| Q2 2021 | $12,249,000 | +26.6% | 157,989 | +0.7% | 0.01% | +25.0% |
| Q1 2021 | $9,672,000 | -3.7% | 156,839 | +1.8% | 0.00% | -20.0% |
| Q4 2020 | $10,046,000 | +30.5% | 154,037 | -0.9% | 0.01% | +25.0% |
| Q3 2020 | $7,700,000 | -10.1% | 155,497 | -13.3% | 0.00% | -20.0% |
| Q2 2020 | $8,561,000 | -22.6% | 179,431 | -31.0% | 0.01% | -37.5% |
| Q1 2020 | $11,067,000 | -29.1% | 260,221 | -1.9% | 0.01% | -11.1% |
| Q4 2019 | $15,616,000 | +15.5% | 265,211 | +0.2% | 0.01% | +12.5% |
| Q3 2019 | $13,526,000 | +20.5% | 264,591 | -0.3% | 0.01% | +14.3% |
| Q2 2019 | $11,228,000 | -9.4% | 265,426 | +5.8% | 0.01% | -12.5% |
| Q1 2019 | $12,398,000 | +1.5% | 250,916 | -11.1% | 0.01% | -11.1% |
| Q4 2018 | $12,211,000 | +7.5% | 282,136 | +41.0% | 0.01% | +28.6% |
| Q3 2018 | $11,361,000 | +12.5% | 200,161 | -0.0% | 0.01% | 0.0% |
| Q2 2018 | $10,102,000 | +29.0% | 200,201 | +27.4% | 0.01% | +16.7% |
| Q1 2018 | $7,828,000 | +11.6% | 157,131 | -7.9% | 0.01% | +20.0% |
| Q4 2017 | $7,013,000 | +35.5% | 170,625 | -2.0% | 0.01% | +25.0% |
| Q3 2017 | $5,175,000 | -12.9% | 174,111 | -2.9% | 0.00% | -20.0% |
| Q2 2017 | $5,944,000 | +82.2% | 179,301 | +62.8% | 0.01% | +66.7% |
| Q1 2017 | $3,262,000 | +10.7% | 110,141 | -7.3% | 0.00% | +50.0% |
| Q4 2016 | $2,948,000 | +12.8% | 118,841 | +2.6% | 0.00% | 0.0% |
| Q3 2016 | $2,614,000 | -5.3% | 115,830 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,760,000 | +6.2% | 115,830 | +5.8% | 0.00% | 0.0% |
| Q1 2016 | $2,599,000 | -14.6% | 109,430 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $3,044,000 | +27.6% | 109,430 | -5.2% | 0.00% | +50.0% |
| Q3 2015 | $2,385,000 | -21.4% | 115,430 | -2.3% | 0.00% | -33.3% |
| Q2 2015 | $3,034,000 | +1.7% | 118,200 | 0.0% | 0.00% | +50.0% |
| Q1 2015 | $2,983,000 | +6.2% | 118,200 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,810,000 | +20.9% | 118,200 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,325,000 | -17.8% | 118,200 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $2,827,000 | -10.1% | 118,200 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $3,143,000 | +38.9% | 118,200 | +5.4% | 0.00% | +50.0% |
| Q4 2013 | $2,262,000 | +10.4% | 112,100 | -4.4% | 0.00% | 0.0% |
| Q3 2013 | $2,048,000 | +8.5% | 117,300 | +4.7% | 0.00% | 0.0% |
| Q2 2013 | $1,888,000 | – | 112,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |